AJP - Endo Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (February 24, 2009). doi:10.1152/ajpendo.90857.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/5/E973    most recent
90857.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abella, J. V.
Right arrow Articles by Park, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abella, J. V.
Right arrow Articles by Park, M.
Submitted on February 23, 2008
Revised on February 13, 2009
Accepted on February 16, 2009

Breakdown of endocytosis in the oncogenic activation of receptor tyrosine kinases

Jasmine Vanessa Abella1 and Morag Park1*

1 McGill University

* To whom correspondence should be addressed. E-mail: morag.park{at}mcgill.ca.

There is increasing evidence to support the concept that the malignant behavior of many tumors is sustained by the deregulated activation of growth factor receptors. Activation of receptor tyrosine kinases (RTKs) by their respective ligand(s) initiates cellular signals which tightly modulate cell proliferation, survival, differentiation and migration to ensure normal tissue patterning. Uncontrolled activation of such signals can therefore have deleterious effects leading to oncogenesis. To date, deregulation of most RTKs have been implicated in the development of cancer although the mechanisms which lead to their deregulation are not yet fully understood (10). RTK endocytosis, the internalization and trafficking of receptors inside the cell, has long been established as a mechanism to attenuate RTK signaling. However, RTKs have been demonstrated that to continue to signal along the endocytic pathway, which contributes to the spatio-temporal regulation of signal transduction. This review will focus on recent advances linking defective endocytosis of RTKs in the development of cancer.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.